Swiss pharmaceutical giant Roche Holdings (NASDAQ:RHHBY) recently announced the acquisition of Ariosa Diagnostics, which makes non-invasive prenatal testing equipment. The terms of the deal were not disclosed by Roche in its press release. According to WHO, there are over 200 million pregnancies worldwide annually and prenatal testing to detect Down syndrome is gaining strong traction.
{iframe}http://www.trefis.com/stock/rhhby/articles/268459/roches-expands-diagnostics-position-with-the-acquisition-of-ariosa/2014-12-04{/iframe}